News tagged with boehringer ingelheim

Staying one step ahead of cancer cells

BRD4 inhibitors are among the most promising new agents in cancer therapy that are currently evaluated in clinical trials. In a study published in Nature today, a team of researchers at the Research Institute of Molecular ...

Sep 15, 2015
popularity10 comments 0

Subscribe to rss feed